These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8817423)

  • 21. Survival and outcome of very low birth weight infants born in a university hospital with level II NICU.
    Sritipsukho S; Suarod T; Sritipsukho P
    J Med Assoc Thai; 2007 Jul; 90(7):1323-9. PubMed ID: 17710972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS.
    Bhandari V; Gavino RG; Nedrelow JH; Pallela P; Salvador A; Ehrenkranz RA; Brodsky NL
    J Perinatol; 2007 Nov; 27(11):697-703. PubMed ID: 17703184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neonatal mortality and morbidity in gestational age shorter than 30 weeks for babies treated primarily in a central hospital. Follow-up studies of an unselected, consecutive patient group].
    Balling K; Eschen CC; Verder H
    Ugeskr Laeger; 2001 Feb; 163(8):1058-61. PubMed ID: 11242662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the survival of newborn babies weighing <1.5 kg in Sagamu, Nigeria.
    Ogunlesi TA
    Arch Gynecol Obstet; 2011 Dec; 284(6):1351-7. PubMed ID: 21336833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of mortality in premature babies with respiratory distress syndrome treated by early rescue surfactant therapy.
    Gahlawat V; Chellani H; Saini I; Gupta S
    J Neonatal Perinatal Med; 2021; 14(4):547-552. PubMed ID: 34120918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RDS and surfactant replacement: the double-edged sword.
    Etherington H; Lawrence J; Davis D
    Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163
    [No Abstract]   [Full Text] [Related]  

  • 28. Surfactant therapy in respiratory distress syndrome: the effect of a learning curve in improving outcome.
    Gormally SM; Clarke TA; Krishnan A; Ali M; Matthews TG
    Ir J Med Sci; 1993 Nov; 162(11):458-61. PubMed ID: 8113035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant therapy in extremely premature infants.
    Merritt TA
    J Pediatr; 1994 Jul; 125(1):172-3; author reply 173-4. PubMed ID: 8021775
    [No Abstract]   [Full Text] [Related]  

  • 30. New avenues in surfactant research.
    Robertson B
    Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993
    [No Abstract]   [Full Text] [Related]  

  • 31. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 32. Surfactant treatment for respiratory distress syndrome following prolonged rupture of membranes.
    Tubman TR; Halliday HL
    Eur J Pediatr; 1990 Jul; 149(10):727-9. PubMed ID: 2209667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine output in infants with respiratory distress syndrome treated with surfactant.
    Hamdan AH; Shaw NJ
    Clin Pediatr (Phila); 2000 Jul; 39(7):421-5. PubMed ID: 10914308
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.
    Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L
    Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042
    [No Abstract]   [Full Text] [Related]  

  • 35. [The influence of antenatal TRH and glucocorticoids therapy for survival rate of extremely low birth infant].
    Leszczyńska-Gorzelak B; Laskowska M; Poniedziałek-Czajkowska E; Oleszczuk J
    Ginekol Pol; 2000 Feb; 71(2):85-91. PubMed ID: 10765604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 37. The scope and extent of exogenous surfactant utilization in Nigerian health care facilities: benefits of its regular use to outcome of premature babies.
    Okonkwo IR; Okolo AA
    J Matern Fetal Neonatal Med; 2020 Apr; 33(8):1276-1281. PubMed ID: 30149744
    [No Abstract]   [Full Text] [Related]  

  • 38. [Surface tension in the lung and its significance in the resuscitation of the newborn].
    Benzer H
    Anaesthesist; 1971 Jul; 20(7):257-9. PubMed ID: 5569071
    [No Abstract]   [Full Text] [Related]  

  • 39. Handling of pharmacological doses of cortisol hemisuccinate by the premature human newborn.
    Branchaud C; Giroud CJ
    Steroids Lipids Res; 1973; 4(5):361-71. PubMed ID: 4800168
    [No Abstract]   [Full Text] [Related]  

  • 40. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.